The Supreme Court expressed its worry over the government's restriction of price control measures to only anti-cancer drugs, questioning wh...

Zerodha founder Nithin Kamath warned that small and microcap stocks account for a substantial share of India’s margin trading facility book...

Hospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...

The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...

The Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is t...

The National Medical Commission has implemented new ethical advertising guidelines affecting doctors and hospitals. These guidelines prohib...

The Indian government plans to announce a new list of cancer drugs for trade margin rationalisation today. Union Health Minister JP Nadda w...

Abhay Soi, chairman of Max Healthcare, commented on scrutiny regarding hospital pricing in India. He stated that hospitals should be evalua...

A British Indian businessman and his ex-wife are fighting extradition to the US over allegations that they defrauded Medicare and other hea...

Karnataka conducted inspections revealing significant price disparities between hospital procurement and patient billing for cancer drugs a...

Hospital stocks extended losses for a second session after the Supreme Court questioned steep markups on cancer drugs and raised concerns o...

Jefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correctio...

In a landmark ruling, the Supreme Court of India highlighted troubling markups on cancer drugs enforced by hospitals, urging a probe into r...

Hospital stocks came under pressure after the Supreme Court raised concerns over steep mark-ups on medicines sold through corporate hospita...

The Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...

Summit Therapeutics share price is up today by 22% after biopharma firm announced AstraZeneca would invest $2 billion in it. British drugma...

The Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The c...